Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy-Reference-Cited by-同舟云学术

Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy

Published:2012-12-11 Issue:1 Volume:78 Page:43-51
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Fardet Laurence,Antuna-Puente Barbara¹,Vatier Camille¹,Cervera Pascale,Touati Amel²,Simon Tabassome,Capeau Jacqueline,Fève Bruno,Bastard Jean-Philippe

Affiliation:

1. INSERM; UMR-S938

2. Unité de Recherche Clinique de l'Est parisien (URC-Est); AP-HP; Hôpital Saint-Antoine

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2012.04348.x/fullpdf

Reference39 articles.

1. Prevalence of long-term oral glucocorticoids prescriptions in UK over the last 20 years;Fardet;Rheumatology (Oxford),2011

2. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study;Fardet;Journal of the American Academy of Dermatology,2007

3. Effects of glucocorticoids on energy metabolism and food intake in humans;Tataranni;American Journal of Physiology,1996

4. Control of terminal differentiation of adipose precursor cells by glucocorticoids;Gaillard;Journal of Lipid Research,1991

5. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells;Aubert;Biochemical Journal,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced hyperglycemia and diabetes;Therapies;2023-10

2. Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique;Médecine des Maladies Métaboliques;2022-11

3. Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders;Seminars in Neurology;2022-10

4. When therapeutic drugs lead to diabetes;Diabetologia;2022-03-04

5. Molecular and Cellular Bases of Lipodystrophy Syndromes;Frontiers in Endocrinology;2022-01-03